scholarly journals Stat Bite US Cervical Cancer Incidence and Mortality Rates By Age In (2007)

2013 ◽  
Vol 105 (18) ◽  
pp. 1338-1338
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Mortality Rates ◽  
Cervical Cancer Incidence ◽  
Incidence And Mortality

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

2020 ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena García ◽  
Lizbeth Acuña Merchán ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background Cancer is widely recognized as a global public health problem. Breast, prostate and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical and prostate cancer across regions and municipalities in Colombia during 2018. Methods We performed a cross-sectional analysis with data from people with breast, prostate or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates were: 18,69 (CI 95%: 18,15–19,25) and 10,48 (CI 95%: 10,07–10,91); 11,34 (CI 95%: 10,90 − 11,78) and 7,58 (CI 95%: 7,22 − 7,96); 5,93 (CI 95%: 5,62 − 6,25) and 4,31 (CI 95%: 4,05 − 4,58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there were a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection and treatment in the country.

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

2020 ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena García ◽  
Lizbeth Acuña Merchán ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background: Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018.Methods: We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results: Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15-19.25) and 10.48 (CI 95%: 10.07-10.91); 11.34 (CI 95%: 10.90-11.78) and 7.58 (CI 95%: 7.22-7.96); 5.93 (CI 95%: 5.62-6.25) and 4.31 (CI 95%: 4.05-4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions: We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

Cervical cancer incidence and mortality rates in Kentucky

2020 ◽  
Vol 158 (2) ◽  
pp. 446-451
Author(s):  
Scott R. Silva ◽  
Jeremy T. Gaskins ◽  
Matthew R. Nichols ◽  
Daniel S. Metzinger ◽  
Sarah L. Todd ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Mortality Rates ◽  
Cervical Cancer Incidence ◽  
Incidence And Mortality

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena ◽  
Lizbeth Acuña ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018. Methods We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15–19.25) and 10.48 (CI 95%: 10.07–10.91); 11.34 (CI 95%: 10.90–11.78) and 7.58 (CI 95%: 7.22–7.96); 5.93 (CI 95%: 5.62–6.25) and 4.31 (CI 95%: 4.05–4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

scholarly journals INCIDENCE AND MORTALITY OF CERVICAL CANCER IN THE OMSK REGION

2019 ◽  
Vol 18 (5) ◽  
pp. 12-17
Author(s):  
O. P. Goleva ◽  
Z. B. Tasova ◽  
O. P. Prudnikova
Keyword(s):  
Cervical Cancer ◽  
Mortality Rate ◽  
Cancer Incidence ◽  
Cancer Mortality ◽  
Mortality Rates ◽  
Rural Populations ◽  
Advanced Cervical Cancer ◽  
Cervical Cancer Incidence ◽  
Incidence And Mortality ◽  
Cervical Cancer Mortality

The purpose of the study was a comparative assessment of the cervical cancer incidence and mortality among females in urban and rural populations of the Omsk region.Material and Methods. The study included females aged over 18 years from urban and rural areas of the Omsk region. According to population-based cancer registry data for the period 2004–16, the crude cancer incidence and mortality rates in urban and rural populations were calculated. The variational and correlation analyzes were used, the differences were assessed using Student t-test.Results. During 2004–16, the cervical cancer incidence among females of the Omsk region showed an increasing tendency, reaching a peak incidence in women aged 35–54. Concerning the cervical cancer mortality rate, it tended to decrease. For rural females, the cervical cancer mortality rate decreased from 10.8 to 9.7 per 100,000 females (p>0.05). For urban females, the mortality rate decreased from 9.2 to 7.5 per 100,000 females (p>0.05). No significant differences in the mortality rates between urban and rural females were found (p>0.05). The tendency towards decreased incidence of advanced cervical cancer (the average decrease being 3.3 % for rural females and 2.8 % for urban females, p>0.05) and increased incidence of early stage cervical cancer (the average rise being 1.8 % and 1.9 %, respectively) was observed.Conclusion. In the Omsk region, the cervical cancer mortality rate for both rural and urban females showed a tendency to decrease. During the study period, the incidence of cervical cancer had increased; however the incidence of advanced cervical cancer had decreased.

scholarly journals Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial

Trials ◽  
2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Lisa P. Spees ◽  
Andrea C. Des Marais ◽  
Stephanie B. Wheeler ◽  
Michael G. Hudgens ◽  
Sarah Doughty ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Cancer Incidence ◽  
Perceived Risk ◽  
Pap Test ◽  
Hpv Testing ◽  
Cervical Cancer Incidence ◽  
Incidence And Mortality

Abstract Background Screening substantially reduces cervical cancer incidence and mortality. More than half of invasive cervical cancers are attributable to infrequent screening or not screening at all. The current study, My Body My Test (MBMT), evaluates the impact of mailed kits for self-collection of samples for human papillomavirus (HPV) testing on completion of cervical cancer screening in low-income, North Carolina women overdue for cervical cancer screening. Methods/design The study will enroll at least 510 US women aged 25–64 years who report no Pap test in the last 4 years and no HPV test in the last 6 years. We will randomize participants to an intervention or control arm. The intervention arm will receive kits to self-collect a sample at home and mail it for HPV testing. In both the intervention and control arms, participants will receive assistance in scheduling an appointment for screening in clinic. Study staff will deliver HPV self-collection results by phone and assist in scheduling participants for screening in clinic. The primary outcome is completion of cervical cancer screening. Specifically, completion of screening will be defined as screening in clinic or receipt of negative HPV self-collection results. Women with HPV-negative self-collection results will be considered screening-complete. All other participants will be considered screening-complete if they obtain co-testing or Pap test screening at a study-affiliated institution or other clinic. We will assess whether the self-collection intervention influences participants’ perceived risk of cervical cancer and whether perceived risk mediates the relationship between HPV self-collection results and subsequent screening in clinic. We also will estimate the incremental cost per woman screened of offering at-home HPV self-collection kits with scheduling assistance as compared to offering scheduling assistance alone. Discussion If mailed self-collection of samples for HPV testing is an effective strategy for increasing cervical cancer screening among women overdue for screening, this method has the potential to reduce cervical cancer incidence and mortality in medically underserved women at higher risk of developing cervical cancer. Trial registration ClinicalTrials.gov NCT02651883, Registered on 11 January 2016.

Breast and cervical cancer incidence and mortality trends in Russia 1980–2013

2018 ◽  
Vol 55 ◽  
pp. 73-80 ◽  
Author(s):  
Anton Barchuk ◽  
Alexander Bespalov ◽  
Heini Huhtala ◽  
Tuvshinjargal Chimed ◽  
Irina Laricheva ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Breast And Cervical Cancer ◽  
Incidence And Mortality

Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?

2017 ◽  
Vol 27 (8S) ◽  
pp. S1-S9 ◽  
Author(s):  
Murat Gultekin ◽  
Irem Kucukyildiz ◽  
Mujdegul Zayifoglu Karaca ◽  
Selin Dundar ◽  
Guledal Boztas ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Registry ◽  
Cancer Incidence ◽  
Gynecological Cancer ◽  
Mortality Rates ◽  
Tumor Type ◽  
Asian Countries ◽  
Gynecological Cancers ◽  
Cervical Cancer Incidence ◽  
National Cancer Registry

ObjectiveThe aim of this study was to evaluate nationwide gynecological cancer trends in Turkey.MethodsNational cancer registry data (2009–2013) of Turkish Ministry of Health were evaluated. Ovarian, cervical, endometrial, vulvar, vaginal, and tubal cancers are evaluated with respect to age of diagnosis, incidence rates within years, stage, histological distributions, and mortality rates. Data were collected from active cancer registry centers, which increased from 23% in 2009 to 47.5% coverage of the whole population by 2012, and mortality data (2010–2015) were obtained from the Turkish Statistical Institute.ResultsA total of 16,023 gynecological cancers were evaluated among 116,940 female patients with cancer (13.7%). Average incidence for gynecological cancers was 22.7 of 100,000, representing 8437 total new cases annually. Incidence changes within time were not statistically significant, when evaluated for each tumor type. Estimated risk of gynecological cancer development before the age of 80 years was 3.08% (95% confidence interval, 3.07–3.09). The most common gynecological cancers were uterine corpus cancers, which were followed by ovarian and cervical carcinomas. Ovarian and uterine cancer incidences were closer to European levels rather than Asian countries, whereas cervical cancer incidence was extremely low. Gynecological cancers constituted an important fraction of cancer-related mortality in women by comprising approximately 10.35% of cancer-related deaths. Mortality rates due to gynecological cancers did not show a statistically significant increase within years.ConclusionsThis is the first national cancer registry report to be published for gynecological cancers by the Turkish Governmental Department. As a result, Turkish gynecological cancer epidemiological data were consistent with the data obtained from European and developed countries rather than Asian countries, except for cervical cancer incidence, which is extremely low.

Sign in / Sign up

Export Citation Format

Share Document